RP Bio Inc. (KOSDAQ:314140)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,780.00
+190.00 (3.40%)
At close: Aug 24, 2026

RP Bio Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
10,2769,84814,1333,20816,8166,269
Short-Term Investments
-3,7774,7029,3501,4881,449
Trading Asset Securities
9,4871,002----
Cash & Short-Term Investments
19,76314,62618,83612,55818,3047,718
Cash Growth
31.28%-22.35%49.99%-31.39%137.16%-16.89%
Accounts Receivable
19,75018,49917,65919,99520,77321,320
Other Receivables
-111.4738.22353.66332.09112.17
Receivables
19,75018,61117,99720,34921,70521,433
Inventory
29,12324,13723,96234,10938,59022,569
Prepaid Expenses
-35.81212.71162.67177.3674.56
Other Current Assets
1,465171.39104.95535.722,266477.83
Total Current Assets
70,10157,58161,11267,71481,04352,272
Property, Plant & Equipment
92,11194,33695,92196,97588,72788,970
Long-Term Investments
2,71766.0966.0966.0966.0966.09
Other Intangible Assets
584.25756.47495.5335.15453.91538.48
Long-Term Deferred Tax Assets
1,3621,324741.131.49-318.05
Other Long-Term Assets
3,6292,1641,1331,0962,7981,573
Total Assets
170,504156,256159,499166,218173,158143,737

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
20,61919,42917,33020,73729,78124,529
Accrued Expenses
-1,9271,3341,7412,0101,779
Short-Term Debt
16,00016,00025,00025,00034,87336,826
Current Portion of Leases
235.84309.07601.391,007676.85651.95
Current Income Taxes Payable
2,147446.11252.0725.14710.76218.3
Other Current Liabilities
10,5046,2946,6588,98610,5797,385
Total Current Liabilities
49,50744,40451,17557,49678,63071,389
Long-Term Leases
3,0073,1394,5934,7742,6352,858
Pension & Post-Retirement Benefits
-983.57912.89616.03--
Long-Term Deferred Tax Liabilities
----237.08-
Other Long-Term Liabilities
1,241531.73515.29584.61519.18501.27
Total Liabilities
53,75549,05857,19663,47182,02174,748

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
4,3334,3334,3334,3334,0973,294
Additional Paid-In Capital
65,36065,34965,34965,34658,82637,431
Retained Earnings
47,13037,57932,68433,12828,26824,160
Treasury Stock
-81.47-81.47-81.47-81.47-81.47-81.47
Comprehensive Income & Other
6.8417.8817.8821.5627.33123.52
Total Common Equity
116,749107,198102,303102,74791,13764,927
Shareholders' Equity
116,749107,198102,303102,74791,13768,989
Total Liabilities & Equity
170,504156,256159,499166,218173,158143,737

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
19,24319,44830,19430,78138,18540,336
Net Cash (Debt)
519.88-4,821-11,359-18,223-19,881-32,618
Net Cash Growth
------
Net Cash Per Share
60.08-557.39-1314.76-1950.62-2791.65-4962.17
Filing Date Shares Outstanding
8.638.658.658.658.186.57
Total Common Shares Outstanding
8.638.658.658.658.186.57
Working Capital
20,59413,1779,93710,2182,413-19,117
Book Value Per Share
13521.5912393.0311827.1611878.4311145.289877.25
Tangible Book Value
116,165106,441101,808102,41190,68364,388
Tangible Book Value Per Share
13453.9212305.5811769.8811839.6811089.779795.34
Land
17,33317,33315,44115,44115,44115,441
Buildings
63,61863,55562,86657,48756,36755,187
Machinery
50,20549,34255,98554,55846,90444,016
Construction In Progress
187.19671.567982,264832.74523.48